TickerFacts.

NextCure, Inc. (NXTC): Net Income

Annual figures by period end, from SEC filings.

-$55.84M
Year ended 2025-12-31
-$42.75M
Trailing 12 months to 2026-06-30
2018-12-31: -$22.80M2019-12-31: -$33.74M2020-12-31: -$36.60M2021-12-31: -$69.39M2022-12-31: -$74.73M2023-12-31: -$62.72M2024-12-31: -$55.65M2025-12-31: -$55.84M-$55.84M
2018-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$55.84Mn/m2026-03-05, From 2025-01-01
2024-12-31-$55.65Mn/m2026-03-05, From 2024-01-01
2023-12-31-$62.72Mn/m2025-03-06, From 2023-01-01
2022-12-31-$74.73Mn/m2024-03-21, From 2022-01-01
2021-12-31-$69.39Mn/m2023-03-02, From 2021-01-01
2020-12-31-$36.60Mn/m2022-03-03, From 2020-01-01
2019-12-31-$33.74Mn/m2021-03-04, From 2019-01-01
2018-12-31-$22.80Mn/a2020-03-12, From 2018-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
NextCure, Inc. (NXTC)2025-12-31-$55.84Mn/m
Opus Genetics, Inc. (IRD)2025-12-31-$49.59Mn/m
Coya Therapeutics, Inc. (COYA)2025-12-31-$21.23Mn/m
Unicycive Therapeutics, Inc. (UNCY)2025-12-31-$26.55Mn/m
Hyperion Defi, Inc. (HYPD)2025-12-31-$45.31Mn/m
Actinium Pharmaceuticals, Inc. (ATNM)2025-12-31-$33.89Mn/m
Vistagen Therapeutics, Inc. (VTGN)2026-03-31-$69.69Mn/m
Akari Therapeutics Plc (AKTX)2025-12-31-$17.30Mn/m
Atossa Therapeutics, Inc. (ATOS)2025-12-31-$34.77Mn/m

Compare NXTC, IRD, COYA, UNCY side by side · Screen every company in Pharmaceutical Preparations ↗